Clinical trial
A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral…
NCT00246246 · Janssen-Ortho Inc., Canada, Industry · Completed
Key facts
| NCT number | NCT00246246 |
|---|---|
| Title | A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder |
| Official title | A Randomized, Open-label Trial of RISPERDAL® CONSTA™ Versus Oral Antipsychotic Care in Subjects With Bipolar Disorder |
| Lead sponsor | Janssen-Ortho Inc., Canada, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | risperidone |
| Enrollment | 48 |
| Start date | Jan 1, 2004 |
| Completion | Apr 1, 2006 |
| First posted | Oct 31, 2005 |
| Last update posted | Feb 11, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: